Cargando…
c-Myb and its Effector COX-2 as an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer
Background: One of our previous studies have demonstrated that the cancer suppressor miR-150 regulated the progression of colorectal cancer (CRC) by down-regulating v-myb avian myeloblastosis viral oncogene homolog (c-Myb). The purpose of present study was to evaluate the prognostic value of the exp...
Autores principales: | Xie, Ruting, Yang, Yongzhi, Zhang, Huizhen, Liu, Hu, Guo, Jing, Qin, Huanlong, Ma, Yanlei, Goel, Ajay, Li, Xinxiang, Wei, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548004/ https://www.ncbi.nlm.nih.gov/pubmed/31205515 http://dx.doi.org/10.7150/jca.27261 |
Ejemplares similares
-
miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb
por: Feng, Junlan, et al.
Publicado: (2014) -
Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer
por: Zhang, Sheng, et al.
Publicado: (2019) -
Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer
por: Yang, Yongzhi, et al.
Publicado: (2019) -
A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer
por: Shan, Zezhi, et al.
Publicado: (2021) -
Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies
por: Ma, Yanlei, et al.
Publicado: (2013)